wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38404422-82244705-C0E7-4CE1-86F5-791CDC9E55CF
Q38404422-82244705-C0E7-4CE1-86F5-791CDC9E55CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-82244705-C0E7-4CE1-86F5-791CDC9E55CF
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
P2860
Q38404422-82244705-C0E7-4CE1-86F5-791CDC9E55CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38404422-82244705-C0E7-4CE1-86F5-791CDC9E55CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38c4135fe57d9f81540a31d707b3606ba694db31
P2860
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study.